Results 111 to 120 of about 29,868 (281)

Hydroxychloroquine Patch Test Positivity in a Patient With Systemic Lupus Erythematosus

Contact Dermatitis, EarlyView.
Alexa G. Ries, Zachary Frost, Zachary Hopkins, Jamie P. Schlarbaum   +3 more
wiley   +1 more source

Prognostic Value of Skin Lesion Characteristics in Subcutaneous Panniculitis‐Like T‐Cell Lymphoma: A Retrospective Cohort Study Assessing the Applicability of T Category of the TNM Classification for Primary Cutaneous Lymphomas Other Than Mycosis Fungoides and Sézary Syndrome

International Journal of Dermatology, EarlyView.
Subcutaneous panniculitis‐like T‐cell lymphoma. Survival outcomes according to the presence of hemophagocytic lymphohistiocytosis (HLH) and T category. Relapse‐free survival was inferior in patients presenting with generalized (T3) skin lesions. Overall survival was poor in patients with HLH. Relapse‐free survival was also reduced in patients with HLH.
Myoung Eun Choi, Joon Min Jung, Soo Hyun Jeon, Chong Hyun Won, Sung Eun Chang, Mi Woo Lee, Woo Jin Lee   +6 more
wiley   +1 more source

Indexes of skin activity and damage in patients with systemic lupus erythematosus – CLASI and R-CLASI

Научно-практическая ревматология
Introduction. Cutaneous Lupus Disease Area and Severity Index (CLASI) and its modified version, the Revised Cutaneous Lupus Erythematosus Disease Areas and Severity Index (R-CLASI) are tools for quantifying skin and mucosal lesions in patients with both ...
А. А. Shumilova, F. A. Cheldieva, К. S. Nurbaeva, Е. I. Travkiva, Т. М. Reshetnyak   +4 more
doaj   +1 more source

Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates

, 2010
The skin is the second most frequently affected organ system in lupus erythematosus. Although only very rarely life threatening — an example is lupus erythematosus-associated toxic epidermal necrolysis — skin disease contributes disproportionally to ...
RD Sontheimer, G. Obermoser, B. Zelger
core   +1 more source

PD‐L1‐Inhibitor‐Associated Hidradenitis Suppurativa

Journal of Cutaneous Pathology, EarlyView.
Annie Jin, Katherine T. Steele, Emily Y. Chu   +2 more
wiley   +1 more source

Evolving treatments for Sjögren disease: current approaches and emerging targets

Internal Medicine Journal, EarlyView.
Abstract Sjögren disease (SjD) is a prevalent systemic autoimmune condition characterised by exocrine gland dysfunction, systemic inflammation and heterogeneous organ involvement. Current management remains largely symptomatic, with no approved disease‐modifying therapies available and substantial unmet clinical need. However, advances in understanding
Mansi Bhurani, Adrian Y. S. Lee, Maureen Rischmueller, Alberta Hoi   +3 more
wiley   +1 more source

Vitamin D and cutaneous lupus erythematosus: effect of vitamin D replacement on disease severity

BackgroundThe main vitamin D source is exposure to ultraviolet radiation, which aggravates cutaneous lupus erythematosus (CLE).ObjectivesThe aims of this study were to identify variables associated with lower serum 25-hydroxyvitamin D [25(OH)D] levels in
Morales Suárez-Varela, María M., Marquina Vila, Amparo, Vilata Corell, Juan José, Cutillas Marco, Eugenia   +3 more
core   +1 more source

Response of Discoid and Subacute Cutaneous Lupus Erythematosus to Recombinant Interferon Alpha 2A

, 1990
Ten patients suffering from discoid lupus erythematosus (DLE) or subacute cutaneous lupus erythematosus (SCLE) were treated with interferon alpha 2a. A marked improvement or clearing of cutaneous lupus erythematosus lesions was observed in eight of them.
Nicolas, Jean-Francois, Lyonnet, Sylvie, Thivolet, Jean, Kanitakis, Jean   +3 more
core   +1 more source

Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman disease

Internal Medicine Journal, EarlyView.
Abstract Idiopathic multicentric Castleman disease (iMCD) is a rare condition. The pathogenesis is incompletely understood; however, interleukin‐6 (IL‐6) is a major mediator. The clinical presentation is heterogeneous, from mild constitutional symptoms to severe multi‐organ failure.
Dipti Talaulikar, Jun Yen Ng, Adam Bryant, Annmarie Bosco, Hugh C. Caterson, Pratyush Giri, Pravin Hissaria, Simon J. Harrison, Stephen Lade, Connull Leslie, Jacinta Perram, H. Miles Prince, Dejan Radeski, Maureen Rischmueller, Craig Wallington‐Gates, Nicholas Weber, Alberta Hoi   +16 more
wiley   +1 more source

Rapid clearance of cutaneous lesions with anifrolumab in SLE (systemic lupus erythematosus) and DLE (discoid lupus erythematosus)

JEADV Clinical Practice
Background Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organs, including the skin. Activation of the Type I interferon pathway is a key pathophysiological factor in SLE. Discoid lupus erythematosus (DLE) is a chronic
E. Parriel, C. Bulai‐Livideanu, M. Severino‐Freire, A. Delpuech, S. Faguer, J. Belliere, A. Huart, C. Paul   +7 more
doaj   +1 more source